# A Study to Describe the Characteristics of Patients Treated With Apremilast for Plaque Psoriasis in Italian Routine Clinical Practice

> **NCT04031027** · — · COMPLETED · sponsor: **Amgen** · enrollment: 184 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** Apremilast

## Key facts

- **NCT ID:** NCT04031027
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-22
- **Primary completion:** 2021-01-27
- **Final completion:** 2021-01-27
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2024-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04031027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04031027, "A Study to Describe the Characteristics of Patients Treated With Apremilast for Plaque Psoriasis in Italian Routine Clinical Practice". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04031027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*